NCT06696365View on ClinicalTrials.gov

iTBS for Alcohol Use Disorder

NARecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 18, 2025

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2027

Conditions
Alcohol Use Disorder (AUD)
Interventions
DEVICE

TMS

The intermittent theta burst (iTBS) will be delivered using the MagVenture MagPro X100 stimulator equipped with a Cool B-70 A/P (combined active \& sham) figure of eight coil. MagVenture MagPro X100 is available commercially and has been FDA approved to treat major depressive disorder and obsessive-compulsive disorder.

Trial Locations (1)

19565

RECRUITING

Caron Treatment Centers, Wernersville

All Listed Sponsors
lead

Nicholas Balderston, PhD

OTHER

NCT06696365 - iTBS for Alcohol Use Disorder | Biotech Hunter | Biotech Hunter